{"@context":"https://schema.org","@type":"DietarySupplement","id":"https://nutripedia.co.uk/items/vitamin-d3","url":"https://nutripedia.co.uk/items/vitamin-d3","name":"Vitamin D3","category":"Vitamins","tagline":"Essential for bone health and immune function, many UK adults may benefit from Vitamin D3 supplementation.","verdict":"strong","evidenceRating":5,"verdictSummary":"Strong evidence for bone health when combined with calcium (6% fracture reduction, 16% hip fracture reduction across 6 trials, n=49,282). Vitamin D alone does not prevent fractures. Modest immune benefit: meta-analysis of 43 RCTs confirms reduced acute respiratory infections (OR 0.92). The VITAL trial (n=25,871, 2,000 IU/day, 5.3 years) found no reduction in cancer incidence or CVD events, but a 25% reduction in cancer deaths after excluding the first 2 years. NHS recommends supplementation for all UK adults in autumn/winter.","dosage":{"recommended":"10–25","unit":"mcg (400–1,000 IU)","timing":"With a fat-containing meal — absorption increases 30–50%","notes":"NHS/SACN RNI: 10 mcg (400 IU) for all UK adults. NICE deficiency treatment: loading of ~300,000 IU over 6–10 weeks then 800–2,000 IU/day maintenance. Oil-based forms (softgels, sprays) generally better absorbed than tablets. Tolerable upper intake: 100 mcg (4,000 IU)/day for adults. D3 preferred over D2."},"keyBenefits":["Essential for calcium absorption and bone mineralisation — prevents rickets and osteomalacia","Supports innate immunity via cathelicidin and defensin upregulation","Modestly reduces acute respiratory infection risk (Lancet D&E, 43 RCTs)","May reduce cancer mortality by 12–13% (3 meta-analyses, not incidence)","Reduces depressive symptoms (SMD: −0.36, 20 RCTs) — stronger for short-term use","Associated with 1.42x lower dementia risk when sufficient (23 prospective studies)"],"warnings":["Toxicity at serum 25(OH)D >375 nmol/L — almost always from supplement overuse, not sun","Primary toxicity risk is hypercalcaemia: nausea, vomiting, kidney stones, cardiac arrhythmias","Do not exceed 100 mcg (4,000 IU)/day without medical supervision","7 major drug interactions — notably thiazide diuretics, digoxin, and antiepileptic drugs","Vitamin D alone (without calcium) shows no fracture protection in RCTs","Contraindicated in hypercalcaemia, sarcoidosis, and severe renal impairment"],"evidenceSummary":{"overall":"moderate","headline":"Research indicates Vitamin D3's role in bone health is well-established, with emerging evidence for immune function and potential benefits in reducing cancer mortality and depressive symptoms, though some areas require further robust investigation.","keyFindings":[{"finding":"Vitamin D3 supplementation showed protective effects on bone mineral density at the lumbar spine, femoral neck, and total hip.","source":"Kazemian et al. 2023, meta-analysis"},{"finding":"Strong evidence indicates vitamin D3 supplementation reduced total cancer mortality (OR 0.90; 95% CI 0.87–0.92).","source":"Petrelli et al. 2024, systematic-review"},{"finding":"Vitamin D exerts dual immunological effects: enhancing innate immunity via upregulation of antimicrobial peptides while promoting immune tolerance by shifting T-helper balance toward anti-inflammatory Th2 responses.","source":"Athanassiou et al. 2022, systematic-review"},{"finding":"Vitamin D supplementation safely reduced the risk of acute respiratory infections overall, with greatest protection observed with daily doses of 400–1,000 IU for up to 12 months in children aged 1–16 years.","source":"Jolliffe et al. 2021, meta-analysis"},{"finding":"Vitamin D supplementation at 2,000 IU/day or above appears to reduce depressive symptoms in adults, with stronger effects in those diagnosed with major depressive disorder, though overall evidence certainty was rated very low.","source":"Mikola et al. 2023, meta-analysis"}]},"dosing":{"commonDose":"10 micrograms (mcg) or 400 International Units (IU) daily, as recommended by SACN for all UK adults. Some research has investigated higher daily doses, such as 800-2000 IU, for specific outcomes.","timing":"Typically taken once daily, often with a meal containing fat to aid absorption as it is a fat-soluble vitamin.","notes":"Consistent daily intake is generally more effective than intermittent high-dose boluses for certain outcomes like cancer mortality and acute respiratory infections. It is advisable to follow national guidelines or consult a healthcare professional regarding appropriate dosing."},"safety":{"generallyRecognisedAs":"safe-at-typical-doses","commonSideEffects":["Hypercalcaemia (at excessive doses)","Nausea (at excessive doses)","Vomiting (at excessive doses)","Weakness (at excessive doses)","Frequent urination (at excessive doses)"],"contraindications":["Individuals with hypercalcaemia","Certain medical conditions affecting calcium regulation (e.g., sarcoidosis, primary hyperparathyroidism)","Kidney disease (consult specialist)","Known allergy or hypersensitivity to vitamin D"],"upperLimit":"100 µg/day (4,000 IU) for adults and adolescents (EFSA)"},"whoMightBenefit":["Individuals with limited sun exposure, especially during autumn and winter months in the UK.","Older adults, due to decreased skin synthesis and potential bone health concerns.","People with darker skin tones, who may have reduced vitamin D synthesis from sunlight.","Those with diagnosed vitamin D deficiency, as identified by a healthcare professional.","Individuals seeking to support bone health and immune function."],"whoShouldAvoid":["Individuals with hypercalcaemia (high blood calcium levels).","Those with certain medical conditions that affect calcium metabolism, such as sarcoidosis or primary hyperparathyroidism.","People taking medications that interact with vitamin D, such as certain diuretics or antiepileptic drugs, without medical supervision.","Individuals with kidney disease, who should consult a specialist before supplementing.","Anyone with a known allergy or hypersensitivity to vitamin D or its components."],"regulatoryNotes":"In the UK, the Scientific Advisory Committee on Nutrition (SACN) recommends a daily intake of 10 micrograms (400 IU) of vitamin D for all individuals aged four years and older, including pregnant and breastfeeding women, to maintain bone and muscle health. The European Food Safety Authority (EFSA) has established a tolerable upper intake level (UL) for vitamin D at 100 micrograms (4,000 IU) per day for adults and adolescents, citing persistent hypercalciuria as the critical adverse effect. Health claims for vitamin D in the EU are regulated by EFSA, allowing claims related to normal absorption/utilisation of calcium and phosphorus, maintenance of normal bones, muscle function, teeth, and immune system function. The Medicines and Healthcare products Regulatory Agency (MHRA) classifies higher dose vitamin D products as medicines. Advertising standards in the UK, overseen by the Advertising Standards Authority (ASA), require health claims to be substantiated by robust scientific evidence.","faqs":[{"question":"Why is vitamin D important for UK residents?","answer":"Due to the UK's latitude, sunlight exposure is insufficient for vitamin D synthesis from October to March. This leads to a high prevalence of deficiency, with national surveys showing many adults have inadequate levels, particularly in winter and among certain ethnic groups. Vitamin D is crucial for maintaining healthy bones, teeth, and muscle function, and supports the immune system."},{"question":"What's the difference between Vitamin D2 and D3?","answer":"Vitamin D3 (cholecalciferol) is the form naturally produced in human skin when exposed to sunlight and found in some animal-sourced foods. Vitamin D2 (ergocalciferol) is plant-derived. Research indicates that D3 is significantly more effective at raising and maintaining blood vitamin D levels than D2."},{"question":"Can I get enough vitamin D from diet alone?","answer":"While some foods like oily fish, fortified cereals, and eggs contain vitamin D, it is challenging for most people to meet the recommended intake through diet alone, especially without adequate sun exposure. This is why supplementation is often recommended, particularly during the darker months in the UK."},{"question":"What are the signs of vitamin D deficiency?","answer":"Vitamin D deficiency often has no obvious symptoms in its early stages. However, prolonged deficiency can lead to bone pain, muscle weakness, and fatigue. In severe cases, it can contribute to conditions like rickets in children and osteomalacia in adults. A blood test is the most reliable way to determine vitamin D status."},{"question":"Is it possible to take too much vitamin D?","answer":"Yes, taking excessively high doses of vitamin D can lead to toxicity, known as hypervitaminosis D. This can cause hypercalcaemia, a build-up of calcium in the blood, which may result in nausea, vomiting, weakness, frequent urination, and in severe cases, kidney problems. The tolerable upper intake level for adults is generally considered to be 4,000 IU (100 mcg) per day by EFSA and NIH."},{"question":"Does vitamin D help with mood or depression?","answer":"A meta-analysis of randomised controlled trials suggests that vitamin D supplementation, particularly at doses of 2,000 IU/day or above, may help reduce depressive symptoms in adults, with stronger effects observed in those diagnosed with major depressive disorder. However, the overall certainty of this evidence is currently rated as very low due to variability in studies. (Mikola et al. 2023, meta-analysis)"},{"question":"Does vitamin D protect against colds and flu?","answer":"A systematic review and meta-analysis found that vitamin D supplementation safely reduced the risk of acute respiratory infections (ARIs) overall. The greatest protective effect was observed with daily doses of 400–1,000 IU for up to 12 months, particularly in children. Bolus dosing did not show significant benefit. (Jolliffe et al. 2021, meta-analysis)"}],"research":{"totalCount":14,"papers":[{"title":"Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines","year":2025,"journal":"Nutrients","doi":"10.3390/nu17020277","pmid":"39861407","url":"https://doi.org/10.3390/nu17020277","studyDesign":"systematic-review","fields":[],"conclusion":"Serum 25(OH)D above 30 ng/mL substantially reduces risks of multiple diseases and mortality compared to levels below 20 ng/mL. The authors recommend daily supplementation of 2,000 IU for general disease prevention and 4,000–6,000 IU to achieve optimal protective serum levels of 40–70 ng/mL.","abstract":"","citationCount":0},{"title":"Vitamin D — Health Professional Fact Sheet","year":2024,"journal":"NIH Office of Dietary Supplements","doi":null,"pmid":"","url":"https://pubmed.ncbi.nlm.nih.gov//","studyDesign":"regulatory","fields":[],"conclusion":"The NIH ODS recommends an RDA of 600 IU/day (ages 1–70) and 800 IU/day (>70 years), with a UL of 4,000 IU/day for adults. Serum 25(OH)D below 30 nmol/L indicates deficiency; 50 nmol/L is considered adequate. Consistent evidence supports bone health benefits; evidence for cancer, CVD, and other outcomes remains inconclusive.","abstract":"","citationCount":0},{"title":"Vitamin D3 and cancer risk in healthy subjects: An umbrella review of systematic review and meta-analysis","year":2024,"journal":"Clinical Nutrition ESPEN","doi":"10.1016/j.clnesp.2024.08.014","pmid":"39178988","url":"https://doi.org/10.1016/j.clnesp.2024.08.014","studyDesign":"systematic-review","fields":[],"conclusion":"Strong evidence indicates vitamin D3 supplementation reduced total cancer mortality (OR 0.90; 95% CI 0.87–0.92). Sufficient vitamin D3 status was associated with potential prevention of head and neck, breast, colorectal, lung, renal cell, and thyroid cancers, supporting routine vitamin D assessment in preventive healthcare.","abstract":"","citationCount":0},{"title":"Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate","year":2023,"journal":"EFSA Journal","doi":"10.2903/j.efsa.2023.8145","pmid":"37560437","url":"https://doi.org/10.2903/j.efsa.2023.8145","studyDesign":"regulatory","fields":[],"conclusion":"The EFSA NDA Panel maintains a tolerable upper intake level of 100 µg/day (4,000 IU) vitamin D equivalents for adults and adolescents, with persistent hypercalciuria as the critical adverse effect. A conversion factor of 2.5 is established for calcidiol monohydrate labelling purposes.","abstract":"","citationCount":0},{"title":"Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial","year":2023,"journal":"BMJ","doi":"10.1136/bmj-2023-075230","pmid":"37380191","url":"https://doi.org/10.1136/bmj-2023-075230","studyDesign":"rct","fields":[],"conclusion":"Monthly high-dose vitamin D3 (60,000 IU) was associated with a modest reduction in major cardiovascular events (HR 0.91) versus placebo in older adults, driven primarily by lower rates of myocardial infarction and coronary revascularisation. The absolute risk difference was small and confidence intervals were consistent with a null finding.","abstract":"","citationCount":0},{"title":"Vitamin D Supplementation and Its Impact on Mortality and Cardiovascular Outcomes: Systematic Review and Meta-Analysis of 80 Randomized Clinical Trials","year":2023,"journal":"Nutrients","doi":"10.3390/nu15081810","pmid":"37111028","url":"https://doi.org/10.3390/nu15081810","studyDesign":"meta-analysis","fields":[],"conclusion":"Across 80 RCTs, vitamin D supplementation was associated with a modest reduction in all-cause mortality (OR 0.95) but showed no statistically significant reduction in cardiovascular-specific mortality or morbidity. The authors conclude that further high-quality trials are required before firm clinical recommendations can be made.","abstract":"","citationCount":0},{"title":"Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants","year":2023,"journal":"Frontiers in Nutrition","doi":"10.3389/fnut.2023.1070808","pmid":"37006940","url":"https://doi.org/10.3389/fnut.2023.1070808","studyDesign":"meta-analysis","fields":[],"conclusion":"Globally, 15.7% of people had severe vitamin D deficiency (25(OH)D <30 nmol/L) and 47.9% had levels below 50 nmol/L. Deficiency was more prevalent in females, high-latitude regions, winter months, and lower-middle-income countries, indicating a substantial global public health burden requiring intervention.","abstract":"","citationCount":0},{"title":"Efficacy of vitamin D3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials","year":2023,"journal":"Ageing Research Reviews","doi":"10.1016/j.arr.2023.101923","pmid":"37004841","url":"https://doi.org/10.1016/j.arr.2023.101923","studyDesign":"meta-analysis","fields":[],"conclusion":"Daily vitamin D3 supplementation reduced cancer mortality by 12% compared to placebo; bolus dosing showed no significant benefit. Subgroup analyses favoured adults aged 70 and older and those initiating supplementation before cancer diagnosis. The overall pooled effect across all 14 RCTs did not reach statistical significance.","abstract":"","citationCount":0},{"title":"Effect of supplemental vitamin D3 on bone mineral density: a systematic review and meta-analysis","year":2023,"journal":"Nutrition Reviews","doi":"10.1093/nutrit/nuac068","pmid":"36308775","url":"https://doi.org/10.1093/nutrit/nuac068","studyDesign":"meta-analysis","fields":[],"conclusion":"Vitamin D3 supplementation showed protective effects on BMD at the lumbar spine, femoral neck, and total hip. Dose-response relationships varied by skeletal site; BMD at the forearm was not improved. Results support targeted supplementation for bone health but highlight the importance of site-specific assessment.","abstract":"","citationCount":0},{"title":"The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials","year":2023,"journal":"Critical Reviews in Food Science and Nutrition","doi":"10.1080/10408398.2022.2096560","pmid":"35816192","url":"https://doi.org/10.1080/10408398.2022.2096560","studyDesign":"meta-analysis","fields":[],"conclusion":"Analysis of 41 RCTs (n=53,235) found that vitamin D supplementation at 2,000 IU/day or above appears to reduce depressive symptoms in adults, with stronger effects in those diagnosed with major depressive disorder. Overall evidence certainty was rated very low due to high heterogeneity and risk of bias.","abstract":"","citationCount":0},{"title":"Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults","year":2022,"journal":"New England Journal of Medicine","doi":"10.1056/NEJMoa2202106","pmid":"35939577","url":"https://doi.org/10.1056/NEJMoa2202106","studyDesign":"rct","fields":[],"conclusion":"Among 25,871 generally healthy adults not selected for vitamin D deficiency or osteoporosis, daily vitamin D3 2000 IU did not significantly reduce risk of total, non-vertebral, or hip fractures compared to placebo over a median 5.3 years of follow-up.","abstract":"","citationCount":0},{"title":"The Immunomodulatory Properties of Vitamin D","year":2022,"journal":"Mediterranean Journal of Rheumatology","doi":"10.31138/mjr.33.1.7","pmid":"35611096","url":"https://doi.org/10.31138/mjr.33.1.7","studyDesign":"systematic-review","fields":[],"conclusion":"Vitamin D exerts dual immunological effects: enhancing innate immunity via upregulation of antimicrobial peptides (cathelicidin, defensins) while promoting immune tolerance by shifting T-helper balance toward anti-inflammatory Th2 responses. Deficiency is consistently associated with greater disease severity in autoimmune and inflammatory conditions.","abstract":"","citationCount":0},{"title":"Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis","year":2022,"journal":"Endocrinology and Metabolism","doi":"10.3803/EnM.2021.1374","pmid":"35504603","url":"https://doi.org/10.3803/EnM.2021.1374","studyDesign":"meta-analysis","fields":[],"conclusion":"Daily vitamin D supplementation at 800–1,000 IU was associated with significantly lower risks of osteoporotic fracture and falls. Higher or lower doses and intermittent dosing regimens did not demonstrate equivalent benefit. Patients with pre-existing vitamin D deficiency showed the greatest risk reduction for falls.","abstract":"","citationCount":0},{"title":"Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials","year":2021,"journal":"Lancet Diabetes & Endocrinology","doi":"10.1016/S2213-8587(21)00051-6","pmid":"33798465","url":"https://doi.org/10.1016/S2213-8587(21)00051-6","studyDesign":"meta-analysis","fields":[],"conclusion":"Vitamin D supplementation safely reduced risk of acute respiratory infections overall (OR 0.92) across 46 RCTs with 75,541 participants. Greatest protection was observed with daily doses of 400–1,000 IU for up to 12 months in children aged 1–16 years. Bolus dosing provided no significant benefit.","abstract":"","citationCount":0}]},"machineReadable":{"markdownUrl":"https://nutripedia.co.uk/items/vitamin-d3/markdown","jsonUrl":"https://nutripedia.co.uk/items/vitamin-d3/json","llmsTxt":"https://nutripedia.co.uk/llms.txt"},"disclaimer":"Informational supplement research only. Not medical advice. Consult a qualified healthcare professional before taking supplements.","lastReviewed":"2026-04-20T00:00:00.000Z","updatedAt":"2026-04-20T00:00:00.000Z"}